A new study suggests the COVID-19 vaccine from Moderna generates twice as many antibodies as the vaccine from Pfizer.
A new study suggests the COVID-19 vaccine from Moderna generates twice as many antibodies as the vaccine from Pfizer.
Researchers just published a study that could speed up the approval process for vaccines and boosters intended to protect people..